232
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Hypertension and Diabetes Management Practices Among Healthcare Workers in Imo and Kaduna States, Nigeria: An Exploratory Study

ORCID Icon, , , ORCID Icon &
Pages 2535-2543 | Published online: 10 Nov 2020

References

  • Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2224–2260. doi:10.1016/S0140-6736(12)61766-823245609
  • WHO. Global Health Observatory (GHO) Data NCD Mortality and Morbidity. World Health Organization; 2018.
  • Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–450. doi:10.1161/CIRCULATIONAHA.115.01891227502908
  • International Diabetes Federation. IDF Diabetes Atlas. 8th ed. IDF Diabetes Atlas; 2017.
  • Campbell NRC, Lackland DT, Niebylski ML. High blood pressure: why prevention and control are urgent and important-a 2014 fact sheet from the world hypertension league and the international society of hypertension. J Clin Hypertens. 2014;16(8):551–553. doi:10.1111/jch.12372
  • Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in southeast Asian and African regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens. 2013;2013:1–14. doi:10.1155/2013/409083
  • Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103(2):150–160. doi:10.1016/j.diabres.2013.11.00124300018
  • Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan africa: a systematic review and meta-analysis. Hypertension. 2015;65(2):291–298. doi:10.1161/HYPERTENSIONAHA.114.0439425385758
  • Schwartz CL, McManus RJ. What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease? BMC Med. 2015;13(1). doi:10.1186/s12916-015-0502-5
  • Owolabi M, Olowoyo P, Miranda JJ, et al. Gaps in hypertension guidelines in low- and middle-income versus high-income countries: a systematic review. Hypertension. 2016;68(6):1328–1337. doi:10.1161/HYPERTENSIONAHA.116.0829027698059
  • Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: national Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013.
  • Odili V, Oghagbon E, Ugwa N, Ochei U, Aghomo O. Adherence to international guidelines in the management of hypertension in a tertiary hospital in Nigeria. Trop J Pharm Res. 2008;7(2). doi:10.4314/tjpr.v7i2.14608
  • Ale OK, Braimoh RW. Awareness of hypertension guidelines and the diagnosis and evaluation of hypertension by primary care physicians in Nigeria. Cardiovasc J Afr. 2017;28(2):72–76. doi:10.5830/CVJA-2016-04828470329
  • Asakitikpi E. A healthcare coverage and affordability in Nigeria: an alternative model to equitable healthcare delivery In: Universal Healthcare. IntechOpen; 2019 Available from https://www.intechopen.com/online-first/healthcare-coverage-and-affordability-in-nigeria-an-alternative-model-to-equitable-healthcare-delive.
  • Okonkwo AD, Okonkwo UP. Patent medicine vendors, community pharmacists and STI management in Abuja, Nigeria. Afr Health Sci. 2010.
  • Cremers AL, Alege A, Nelissen HE, et al. Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study. J Hypertens. 2019;37(2):389–397. doi:10.1097/HJH.000000000000187730645210
  • Osamor P, BE O. Factors associated with treatment compliance in hypertensives in South West Nigeria. J Heal Popul Nat. 2011.
  • Dzudie A, Ojji D, Anisiuba BC, et al. Development of the roadmap and guidelines for the prevention and management of high blood pressure in Africa: proceedings of the PASCAR: hypertension task force meeting: nairobi, Kenya, 27 October 2014. Cardiovasc J Afr. 2014.
  • Piper MA, Evans CV, Burda BU, Smith N. Screening for high blood pressure in adults: a systematic evidence review for the U.S. preventive services task force. screen high blood press adults a system. Evid Rev US Prev Serv Task Force. 2014 121 Available from http://www.ncbi.nlm.nih.gov.proxy.med.sc.edu/books/NBK269495/%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/25632496.
  • World Health Organization. Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low-Resource Settings. WHO Libr Cat Data; 2012.
  • Okubadejo NU, Ozoh OB, Ojo OO, et al. Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations. Clin Hypertens. 2019;25(1). doi:10.1186/s40885-019-0112-1.
  • Chiolero A, Paradis G, Paccaud F. The pseudo-high-risk prevention strategy. Int J Epidemiol. 2015;44(5):1469–1473. doi:10.1093/ije/dyv10226071137
  • Cherie A, Mitkie G, Ismail S, Berhane Y. Perceived sufficiency and usefulness of IEC materials and methods related to HIV/AIDS among high school youth in Addis Ababa, Ethiopia. Afr J Reprod Health. 2005;9(1):66–77. doi:10.2307/358316116104656
  • World Health Organization International Society of Hypertension Writing Group. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;2003.
  • Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586–1593. doi:10.1007/s00125-017-4336-x28770321
  • Mosenzon O, Pollack R, Raz I. Treatment of Type. Vol. 2 Diabetes: From guidelines to position statements and back recommendations of the Israel National Diabetes Council. Diabetes Care; 2016.
  • Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;2013.
  • Olowofela A, Isah A. Antihypertensive medicines prescriptions before and after the Nigeria hypertension society guidelines and prescriber’s awareness of the guideline. Niger Med J. 2017;58(3):107. doi:10.4103/nmj.NMJ_131_1629962652
  • Chou CC, Lee MS, Ke CH, Chung MH. Prescription patterns of hypertension - National Health Insurance in Taiwan. J Chinese Med Assoc. 2004;67(3):123–130.
  • Mori H, Ukai H, Yamamoto H, et al. Current status fo antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res. 2006;29(3):143–151. doi:10.1291/hypres.29.14316755149
  • Adigun AQ, Ishola DA, Akintomide AO, Ajayi AAL. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. J Hum Hypertens. 2003;17(4):277–285. doi:10.1038/sj.jhh.100153812714973
  • Wassertheil-Smoller S, Psaty B, Greenland P, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. J Am Med Assoc. 2004.
  • Webb AJS, Rothwell PM. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke. 2011;42(10):2860–2865. doi:10.1161/STROKEAHA.110.61156621817143
  • Jarari N, Rao N, Peela JR, et al. A review on prescribing patterns of antihypertensive drugs. Clin Hypertens. 2015;22(1). doi:10.1186/s40885-016-0042-0.
  • Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–297. doi:10.1007/s00125-005-0097-z16391903